Shuyong Zhao

机构：Buchang Pharma (China), Shanghai Institute of Pharmaceutical Industry

发表论文 16 篇 · 总被引 56 次 · h-index 4

代表论文

Iruplinalkib (WX‑0593), a novel ALK/ROS1 inhibitor, overcomes crizotinib resistance in preclinical models for non-small cell lung cancer (2023 · Investigational New Drugs · 被引 19)
Discovery and preclinical evaluations of WX-0593, a novel ALK inhibitor targeting crizotinib-resistant mutations (2022 · Bioorganic & Medicinal Chemistry Letters · 被引 15)
A Biomimetic Adhesive Disc for Robotic Adhesion Sliding Inspired by the Net-Winged Midge Larva (2024 · Soft Robotics · 被引 8)
Disulfiram impairs USP21-mediated MOF-K257 deubiquitination to inhibit esophageal squamous cell carcinoma progression (2024 · Cancer Letters · 被引 7)
Abstract 3495: QL535, A novel CD2-costimulating T cell engager targeting PSMA-positive prostate cancer matching CD28 trispecific antibody in cytotoxicity, minimizing cytokine release and T-cell exhaustion (2025 · Cancer Research · 被引 2)
A Biomimetic Robot Crawling Upstream using Adhesive Suckers Inspired by Net-winged Midge Larvae (2024 · 被引 2)